Back
Cartesian Therapeutics Vs. Amgen Industry Stock Comparison
Sell
40
RNAC
Cartesian Therapeutics
Last Price:
18.99
Seasonality Move:
13.13%
Sell
38
AMGN
Amgen
Last Price:
294.52
Seasonality Move:
9.62%
Sell
40
Cartesian Therapeutics (RNAC)
is a Sell
Is Cartesian Therapeutics a Buy, Sell or Hold?
- The current Cartesian Therapeutics [RNAC] share price is $18.87. The Score for RNAC is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- RNAC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Amgen (AMGN)
is a Sell
Is Amgen a Buy, Sell or Hold?
- The current Amgen [AMGN] share price is $294.53. The Score for AMGN is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- AMGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RNAC Stock Price Chart
What is Cartesian Therapeutics's stock price today?
-
The Cartesian Therapeutics share price today is $18.87
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RNAC is experiencing buying pressure, which is a positive indicator for future bullish movement.
RNAC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.71 | Sell |
| Relative Strength Index (14 RSI): | 49.49 | Sell |
| Chaikin Money Flow: | 56766 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.74 - 21.66) | Sell |
| Bollinger Bands (100): | (14.35 - 20.33) | Buy |
AMGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -8.97 | Sell |
| Relative Strength Index (14 RSI): | 40.27 | Sell |
| Chaikin Money Flow: | 2042722 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (293.73 - 323.09) | Sell |
| Bollinger Bands (100): | (309.75 - 334.27) | Sell |
RNAC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.5 | Buy |
| 20-day SMA: | 19.15 | Sell |
| 50-day SMA: | 19.39 | Sell |
| 200-day SMA: | 19.98 | Sell |
| 8-day EMA: | 17.91 | Buy |
| 20-day EMA: | 18.75 | Buy |
| 50-day EMA: | 18.93 | Sell |
| 200-day EMA: | 20.95 | Sell |
AMGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 289 | Buy |
| 20-day SMA: | 306.32 | Sell |
| 50-day SMA: | 316.75 | Sell |
| 200-day SMA: | 305.77 | Sell |
| 8-day EMA: | 292.57 | Buy |
| 20-day EMA: | 302.07 | Sell |
| 50-day EMA: | 312.08 | Sell |
| 200-day EMA: | 306.79 | Sell |
Cartesian Therapeutics Earnings Growth & RNAC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.90 per share, and an increase next year of $1.70 per share.
Amgen Earnings Growth & AMGN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.03 per share, and an increase next year of $1.07 per share.
Cartesian Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amgen Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||